发明名称 BENZENE COMPOUNDS
摘要 <p>It is intended to provide benzene compounds represented by the following formulae and analogs thereof which exert an ACC activity inhibitory effect and are efficacious in treating hyperlipemia, fatty liver, impaired glucose tolerance, diabetes, diabetic complications (diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy and diabetic great vessel), hypertension and arteriosclerosis.</p>
申请公布号 WO2005108370(A1) 申请公布日期 2005.11.17
申请号 WO2005JP07392 申请日期 2005.04.18
申请人 AJINOMOTO CO., INC.;SUZUKI, NOBUYASU;NIHEI, YUKIO;ICHINOSE, HIDEHIRO;TANAKA, HIDEYUKI;YASA, NORIKO;HATANAKA, TOSHIHIRO;MASUZAWA, YOUKO;NAKANISHI, EIJI;KONDO, NOBUO 发明人 SUZUKI, NOBUYASU;NIHEI, YUKIO;ICHINOSE, HIDEHIRO;TANAKA, HIDEYUKI;YASA, NORIKO;HATANAKA, TOSHIHIRO;MASUZAWA, YOUKO;NAKANISHI, EIJI;KONDO, NOBUO
分类号 A61K31/167;A61K31/18;A61K31/192;A61K31/194;A61K31/198;A61K31/216;A61K31/341;A61K31/381;A61K31/402;A61K31/4035;A61K31/4245;A61K31/4402;A61K31/4409;A61K31/4439;A61K31/445;A61K31/455;A61K31/47;A61K31/4709;A61K31/473;A61K31/496;A61K31/501;A61K31/502;A61K31/5377;A61K31/551;A61K45/00;A61P1/16;A61P3/06;A61P3/10;A61P9/00;A61P9/10;A61P9/12;A61P13/12;A61P25/02;A61P27/02;C07C233/66;C07C275/30;C07C311/16;C07C311/21;C07C311/51;C07D207/06;C07D207/16;C07D207/26;C07D207/40;C07D207/44;C07D207/452;C07D209/44;C07D209/48;C07D211/60;C07D213/36;C07D213/81;C07D213/82;C07D215/20;C07D215/48;C07D221/14;C07D235/18;C07D271/06;C07D277/28;C07D277/30;C07D307/52;C07D333/24;C07D401/06;C07D401/10;C07D401/12;C07D405/04;C07D405/12;C07D409/12;C07D413/04;C07D413/06;C07D413/12;C07D413/14;C07D417/04;C07D417/10;C07D417/12;C07D417/14;C07F9/653;(IPC1-7):C07D215/20;A61K31/537;A61K31/470;A61K31/443;A61K31/440;A61K31/424;A61K31/403 主分类号 A61K31/167
代理机构 代理人
主权项
地址